中国
心脏病
医学
疾病管理
疾病
重症监护医学
内科学
心脏病学
政治学
法学
帕金森病
作者
Kai Ma,Qiyu He,Zheng Dou,Xiaotong Hou,Xi Li,Ju Zhao,Chenfei Rao,Zicong Feng,Kun Sun,Xinxin Chen,Yihua He,Hao Zhang,Shoujun Li
标识
DOI:10.1016/s2352-4642(23)00076-7
摘要
Summary
China has the largest number of individuals with congenital heart disease (CHD) in the world and a heavy burden of CHD. Therefore, understanding current CHD treatment outcomes and patterns in China will contribute to global progress in CHD treatment and be a valuable experience. Generally, CHD treatment in China has satisfactory outcomes owing to the joint efforts by all relevant stakeholders across the country. However, efforts are needed to overcome the remaining challenges: management of mitral valve disease and paediatric end-stage heart failure needs to be improved; cohesive paediatric cardiology teams should be established and collaboration between hospitals enhanced; CHD-related medical resources need to be more accessible and equitable; and nationwide CHD databases should be enhanced. In the second paper of this Series, we aim to systematically summarise the current CHD treatment outcomes in China, discuss potential solutions, and provide future perspectives.
科研通智能强力驱动
Strongly Powered by AbleSci AI